Bright Minds Biosciences Inc. · CSE:DRUG
Adage Capital Management, L.P. reported a 5.58% stake in Bright Minds Biosciences Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 13, 2025
Adage Capital Management, L.P. reported a 5.58% stake in Bright Minds Biosciences Inc., 395,743 shares, as a passive investor on Sep 30, 2025. Filed Nov 13, 2025 (Schedule 13G).
- Stake
- 5.58%
- Shares
- 395,743
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Adage Capital Management, L.P. | 5.58% | 395,743 |
| Robert Atchinson | 5.58% | 395,743 |
| Phillip Gross | 5.58% | 395,743 |
Source
Related
- Bright Minds Biosciences Inc.
- Adage Capital Management, L.P.
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026